U.S. Single Cell Analysis Market Size & Outlook, 2026-2033
The single cell analysis market in the United States is expected to reach a projected revenue of US$ 9,190.3 million by 2033. A compound annual growth rate of 21.05% is expected of the United States single cell analysis market from 2026 to 2033.
In terms of revenue, U.S. accounted for 37.5% of the global single cell analysis market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. single cell analysis market is projected to lead the regional market in terms of revenue in 2033.
Mexico is the fastest growing regional market in North America and is projected to reach USD 707.1 million by 2033.
The U.S. accounts for the most clinical development in life sciences technologies for applications in oncology and infectious diseases. The successful completion of the human genome project has contributed to the development of personalized medicine approaches.
Moreover, the introduction of automated solutions is anticipated to increase the adoption of single-cell analysis tools among end users. For instance, in January 2024, BD announced a collaboration with Hamilton Ink, a robotics developer organization, to support the creation of automated solutions for single-cell multiomics research purposes.
Moreover, as a part of the partnership, BD announced the development of reagent kits for BD Rhapsody Single-Cell Analysis Library Preparation, which would be compatible with Hamilton’s Micro lab NGS STAR robotic liquid handling platform.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Single Cell Analysis Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 63.66% in 2025.
Horizon Databook has segmented the U.S. single cell analysis market based on instruments, consumables covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. accounts for the most clinical development in life sciences technologies for applications in oncology and infectious diseases. The successful completion of the human genome project has contributed to the development of personalized medicine approaches.
Moreover, the introduction of automated solutions is anticipated to increase the adoption of single-cell analysis tools among end users. For instance, in January 2024, BD announced a collaboration with Hamilton Ink, a robotics developer organization, to support the creation of automated solutions for single-cell multiomics research purposes.
Moreover, as a part of the partnership, BD announced the development of reagent kits for BD Rhapsody Single-Cell Analysis Library Preparation, which would be compatible with Hamilton’s Micro lab NGS STAR robotic liquid handling platform.
U.S. Single Cell Analysis Market Product Outlook (Revenue, USD Million , 2021-2033)
Consumables
Instruments
U.S. Single Cell Analysis Market Application Outlook (Revenue, USD Million , 2021-2033)
Cancer
Immunology
Neurology
Stem Cell
Non invasive prenatal diagnosis
In vitro Fertilisation
Other Application
U.S. Single Cell Analysis Market Workflow Outlook (Revenue, USD Million , 2021-2033)
Single Cell Isolation & Library Preparation
Downstream Analysis
Data Analysis
U.S. Single Cell Analysis Market End Use Outlook (Revenue, USD Million , 2021-2033)
Academic & Research Laboratories
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Other End Use
Reasons to subscribe to Single Cell Analysis Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Single Cell Analysis Market Outlook databook
Our clientele includes a mix of Single Cell Analysis Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Single Cell Analysis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Single Cell Analysis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Single Cell Analysis Market, 2021-2033 (US$M)